U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5970981

Mouthguard made at least partially from an edible candy

A mouthguard includes a U-shaped upper bite plate which removably fits over upper teeth of a person, with the entire upper bite plate being made from a soft, deformable and edible gummi candy.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 424/752 - Containing or obtained from Ginkgo (e.g., ginkgo biloba, maidenhair, etc.)


Subclass of Class 424 - Drug, bio-affecting and body treating compositions
Definition: Subject matter wherein the plant material or plant extract
No. of applications: 167
Last issue date: 01/19/2012


1          
Application No.Application TitleIssue Date
20120014934Enhanced Natural Colors
A natural color is concentrated to intensify color range and to provide useful amounts of one or more of anti-oxidant, nutritional, and anti-inflammatory compounds derived from one or more pigment sources. In a preferred embodiment, the pigment source is a fruit, a vege...
01/19/2012
20110318321CONTROLLED RELEASE PHARMACEUTICAL OR FOOD FORMULATION AND PROCESS FOR ITS PREPARATION
The present invention relates to a controlled release pharmaceutical or food formulation comprising at least one active pharmaceutical or food ingredient dispersed in a mixture of a glycogen with a polysaccharide, and the process for its preparation. The invention also ...
12/29/2011
20110305781Use of Eclipta Prostrata and Other PPAR-GAMMA Inhibitors in Cosmetics and Compositions Thereof
The present invention describes compositions and methods for improving the appearance of skin, particularly, treating, ameliorating, preventing, delaying, and/or improving one or more signs of excess accumulation and/or production of subcutaneous fat, such as cellulite,...
12/15/2011
20110280962METALLIZATION DEVICE AND METHOD
The present invention concerns a topical formulation for the treatment of cellulite, comprising alfalfa herb and derivatives thereof and can further comprise melatonine.

The invention refers also to a method of application of said formulati...

11/17/2011
20110256118ANTIOXIDANT-CONTAINING FOOD COMPOSITION FOR USE IN ENHANCING ANTIVIRAL IMMUNITY IN COMPANION ANIMALS
The invention encompasses methods for enhancing the ability of a companion animal to resist and/or overcome viral infections. The methods of the invention include an amount of lipoic acid that is effective in enhancing the antiviral immunity of a companion animal....
10/20/2011
20110250300COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATING TO OXIDATIVE STRESS
The present invention features methods for treating or preventing conditions, diseases, or disorders related to oxidative stress. In one embodiment, the method increases Nrf2 biological activity or expression. In particular, the invention provides for the treatment or p...
10/13/2011
20110236508L-ARGININE-BASED FORMULATION FOR ORAL ABSORPTION
A formulation comprising large quantities of l-arginine and/or fat plaque dissolving agents which is palatable, stench free, and does not evoke nausea. The formulation is adapted to facilitate the adsorption of l-arginine to the blood system and to introduce high levels...
09/29/2011
20110230816Gels for Transdermal Delivery
The present disclosure provides hydrogels that are suitable for drug delivery. In embodiments, hydrogels of the present disclosure may be used for transdermal delivery of bioactive agents, including drugs. The hydrogels of the present disclosure may also be useful as co...
09/22/2011
20110217252COMPOUND USEFUL FOR TREATING CELLULITE
It is described the use of propionyl L-carnitine for treating disturbances of the skin such as cellulite....
09/08/2011
20110189161NUTRIGENOMICS METHODS AND COMPOSITIONS
The present invention provides a proprietary compositions and systems to modulate genetic and metabolomic contributing factors affecting disease diagnosis, stratification, and prognosis, as well as the metabolism, efficacy and/or toxicity associated with specific vitami...
08/04/2011
20110189318METHODS FOR ENHANCING THE EXPRESSION OF INTRACELLULAR REDOX-ASSOCIATED FACTORS
The present invention provides methods for enhancing expression of a redox-associated factor, wherein kaempferol, quercetin or glycosides thereof, or any combination thereof is used as an active ingredient, and methods for enhancing expression of a redox-associated fact...
08/04/2011
20110182885FORMULATIONS AND TREATMENTS FOR WELL-BEING
A formulation for well-being in humans including: extracts from the herbal varieties, Polygonum multiflorum, Panax quinquefolium, Gingko biloba, and Equisetum arvense; beta sitosterol methyl sulfonyl methane; soy isoflavones; levo-arginine; inositol; niaci...
07/28/2011
20110171328PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES
The invention discloses a pharmaceutical composition for synergistically treating and preventing diabetic complication. The composition contains 1-deoxynojirimycin and fagomine, and the weight ration of the 1-deoxynojirimycin to the fagomine is 0.5-5:1....
07/14/2011
20110159123Composition For Relieving Premenstrual Syndrome
A composition is provided for relieving premenstrual syndrome. The composition comprises about 5% to about 95% by weight of a tribulus terrestris extract and about 5% to about 95% by weight of one or more herbal extracts selected from organic white willow extract, Red r...
06/30/2011
20110142956USE OF A PDE 5 INHIBITOR FOR TREATING AND PREVENTING HYPOPIGMENTARY DISORDERS
The invention relates to the use of PDE5 inhibitors for treating and/or preventing hypopigmentary disorders....
06/16/2011
20110117194PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKER
The present invention provides a pharmaceutical formulation containing an angiotensin-II receptor blocker and a release-control material as a pharmacologically active ingredient and a pharmaceutical formulation comprising an immediate-release compartment and an extended...
05/19/2011
20110091585HERBAL COMPOSITIONS AND METHODS FOR ENHANCING VITAL ENERGY AND ATHLETIC PERFORMANCE
Compositions, kits and methods are provided for enhancing vital energy and athletic performance, improving or restoring blood circulation, promoting mental acuity, reducing fatigue, and improving aerobic performance. In one embodiment, the composition comprises the herb...
04/21/2011
20110085992COMPOSITION FOR PREVENTING INFECTION OF NEW INFLUENZA A (H1N1) VIRUS COMPRISING GINKGO EXTRACT, AIR FILTER COMPRISING THE SAME, AND AIR CLEANING DEVICE COMPRISING THE FILTER
Disclosed are a composition for the prophylaxis of new influenza A (H1N1) virus infection comprising a ginkgo extract, an air filter coated with the same, and an air cleaner comprising the air filter. Having high inhibitory activity against new influenza A (H1N1)...
04/14/2011
20110086119Preparation for the relief of disease
A composition including (a) a Platelet Activating Factor (PAF) Inhibitor and (b) an antioxidant which interferes with the arachidonic acid cascade and also has antioxidant activity. The composition is useful for the treatment or the relief of inflammatory diseases, thro...
04/14/2011
20110086118COMPOSITION FOR PREVENTION OF INFLUENZA VIRAL INFECTION COMPRISING SUMAC EXTRACT, AIR FILTER COMPRISING THE SAME AND AIR CLEANING DEVICE COMPRISING THE FILTER
Disclosed are a composition for the prophylaxis of influenza viral infection comprising a sumac extract, an air filter coated with the same, and an air cleaner comprising the air filter. Having high inhibitory activity against influenza virus, the composition comprising...
04/14/2011
20110070316Antimicrobial Compositions Containing Synergistic Combinations of Quaternary Ammonium Compounds and Essential Oils and/or Constituents Thereof
The present invention relates to compositions comprising quaternary ammonium compounds and essential oils or individual constituents thereof which exhibit enhanced antimicrobial effects. Such combinations may be comprised in lotions, gels, creams, soaps, etc. for applic...
03/24/2011
20110038813Novel Compositions Against Alkyl-Acyl GPC, The Derivatives And Products Thereof
The invention refers to novel compositions with at least one prehormone, hormone from group consisting of mevalonate derivatives or from the group consisting of peptides and/or proteo-hormones and at least one mineral, one constituent by preference from the group consis...
02/17/2011
20110033556Natural Pharmaceutical Preparations for Increasing Albumin
A natural pharmaceutical preparation for treating hypoproteinemia, includes at least one member selected from the group consisting of a drug of increasing human serum albium, a drug of improving and enhance immunity, a drug of treating hepatitis B, a drug of treating He...
02/10/2011
20100310653USE OF AN EXTRACT MADE OF LEAVES OF GINKGO BILOBA
The present invention relates to the use of an extract made of leaves of Ginkgo biloba for the production of a preparation, or an extract made of leaves of Ginkgo biloba as an agent for the treatment and prophylaxis of the dementia syndrome, the early stag...
12/09/2010
20100303784PREPARATION FOR THE PREVENTION AND/OR TREATMENT OF VASCULAR DISORDERS
The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions:
    • ...
12/02/2010
20100285147CRUDE DRUG EXTRACT-BLENDED LIQUID MEDICINE
Provided an acidic liquid preparation containing a herb and/or animal-origin extract at high concentration to suppress time-dependent occurrence of precipitation and/or opacity.

A liquid preparation containing a herb-origin extract having p...

11/11/2010
20100247688PIRENZEPINE AND DERIVATIVES THEREOF AS ANTI-AMYLOID AGENTS
The present invention relates to a compound that is capable of inhibiting the formation of β-amyloid plaques, of reducing and/or retarding the increase the β-amyloid plaque load in the brain of an animal, particularly a mammal, but especially a human. In particular, t...
09/30/2010
20100233304COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE RELEASING COMPOUNDS AND USE THEREOF FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS
Compositions comprising one or more unsaturated fatty acids and one or more nitric oxide releasing compounds, and methods for using such compositions for enhancing cognitive function, reducing or preventing a decline of social interaction, reducing or preventing age-rel...
09/16/2010
20100233301TOPICAL COMPOSITIONS COMPRISING FERMENTED EXTRACTS OF TRADITIONAL CHINESE MEDICINAL (TCM) INGREDIENTS, AND METHODS OF MAKING AND USING SAME
The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for differe...
09/16/2010
20100215774FILM COMPRISING NITROGLYCERIN
The present invention is related to the composition and methods of manufacture of orally-dissolvable, edible films as a vehicle for the non-invasive administration of nitroglycerin and/or other active drugs through the mucosal tissues of the oral cavity. The films inclu...
08/26/2010
20100203103THERAPEUTIC COMPOSITIONS FOR TREATMENT OF INFLAMMATION OF OCULAR AND ADNEXAL TISSUES
The present invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-1 and methods for using this composition to treat inflammatory disease of ocular and adnexal tissues by topical administration. The present invention also di...
08/12/2010
20100196496COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF
There are provided various compounds and compositions comprising polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds and compositions can be useful as cancer chemopreventive agents. They can also be useful for enhancing solubility of vario...
08/05/2010
20100189818SORBIC AND BENZOIC ACID AND DERIVATIVES THEREOF ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL
Methods and compositions are provided for treating neuropsychiatric disorders such as schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, and bipolar disorder. The methods entail administering to a patient diagnosed as having a ne...
07/29/2010
20100151064THIAZOLHYDRAZIDES FOR TREATMENT OF NEURODEGENERATIVE DISEASES
Described are compounds having a thiazolhydrazide scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said...
06/17/2010
20100112104COSMETIC PREPARATIONS DESIGNED TO REDUCE UNSIGHTLY CELLULITE
The invention relates to a new derivative of aryldimethylpyrazolone of formula (I) which is effective in reducing unsightly cellulite, and compositions containing it.

...

05/06/2010
20100080764Skin Treatment Systems
A basic facial and body treatment cosmetic formulation is a combination of a cationic emulsifying agent, an oil soluble liquid polymer and a naturally occurring lactate buffer system. The basic formulation is a starter system that can be specialized to skin moisturizers...
04/01/2010
20100068259NATURAL PRODUCT INHIBITORS OF 3DG
Compositions are disclosed which have as a component thereof an inhibitor of the enzymatic production of 3-deoxyglucosone (3DG) from fructoselysine and/or an inactivator of 3DG, and which are useful for the treatment or prophylaxis of a condition or disease state that i...
03/18/2010
20100062067COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT
A composition comprising lipid and surfactant, characterised in that the lipid and surfactant are in the form of macromolecular assemblies of less than 100 nm in diameter. The surfactant can have a HLB number of less than 20, or be an ether or ester surfactant, or be io...
03/11/2010
20100028318AGENT FOR RELIEF OR PREVENTION OF XEROSTOMIA
The present invention has its object to provide a safer and highly effective composition capable of relieving or preventing xerostomia. The present invention relates to an agent for relieving or preventing xerostomia comprising an oxidized coenzyme Q and/or a reduced co...
02/04/2010
20100015259Composition and method for improving human concentration, memory and other cognitive brain
This formulaic composition has synergistic effects on the mental function of humans including reduction of mental fatigue, maintenance and enhancement of concentration and mental vigor. The main components are theanine, at levels in excess of 200 mg/dose, and Gingko Bil...
01/21/2010
1          
 
Sign InRegister
Username  
Password   
forgot password?